Charcot joint disease in diabetes mellitus

Related Experiment Video

Updated: Aug 31, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

Lieke Lee1, Peter A Blume, Bauer Sumpio

  • 1Department of Orthopaedics and Rehabilitation, Section of Podiatric Surgery, Yale School of Medicine, Yale-New Haven Hospital, New Haven, CT, USA.

Annals of Vascular Surgery
|September 26, 2003
PubMed

Insights

Diabetic foot problems can include Charcot joint disease (CJD), a serious condition causing foot deformities. Early detection and treatment of CJD are crucial to prevent severe complications and limb loss in diabetic patients.

Area of Science:

  • Podiatry
  • Diabetology
  • Vascular Surgery

Background:

  • Diabetes mellitus is the leading cause of Charcot joint disease (CJD).
  • CJD often presents subtly, leading to delayed diagnosis and severe foot deformities.
  • Diabetic foot complications, including CJD, pose a significant risk to limb health.

Purpose of the Study:

  • To provide a comprehensive overview of Charcot joint disease in diabetic patients.
  • To discuss the pathogenesis, clinical presentation, and diagnostic methods for CJD.
  • To review current treatment strategies for managing CJD and its complications.

Main Methods:

  • Literature review on Charcot joint disease in diabetes.
  • Analysis of clinical presentations and diagnostic modalities.
  • Synthesis of treatment approaches for CJD.

Main Results:

  • CJD is a progressive degenerative arthropathy primarily affecting the foot joints in diabetic individuals.
  • Subtle early signs of CJD are often missed, leading to advanced deformities and increased risk of ulceration and osteomyelitis.
  • Prompt diagnosis and intervention are essential to mitigate CJD's destructive effects.

Conclusions:

  • Vascular surgeons must be aware of CJD in diabetic patients presenting with foot issues.
  • Early recognition and management of CJD are critical for preserving foot structure and preventing limb-threatening complications.
  • A multidisciplinary approach is often necessary for optimal CJD patient care.

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...